Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1880
+0.0100 (5.62%)
At close: Mar 27, 2026

HKG:6833 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3823604004885393,517
Market Cap Growth
3.30%-10.15%-17.92%-9.43%-84.68%604.67%
Enterprise Value
3093554571534053,596
Last Close Price
0.190.180.190.230.251.78
PE Ratio
9.949.288.9510.466.8621.21
Forward PE
-15.2815.2815.2815.2815.28
PS Ratio
0.160.160.130.170.211.42
PB Ratio
0.490.470.570.710.797.64
P/TBV Ratio
0.600.570.640.810.917.64
P/FCF Ratio
---1.3721.2810.15
P/OCF Ratio
---1.256.359.37
EV/Sales Ratio
0.130.150.150.060.161.45
EV/EBITDA Ratio
2.983.423.241.093.2914.82
EV/EBIT Ratio
3.724.273.771.203.5415.21
EV/FCF Ratio
---0.4315.9910.38
Debt / Equity Ratio
0.260.260.530.400.320.91
Debt / EBITDA Ratio
1.971.972.531.891.711.71
Debt / FCF Ratio
---0.788.591.21
Net Debt / Equity Ratio
-0.09-0.090.06-0.30-0.230.04
Net Debt / EBITDA Ratio
-0.71-0.710.32-1.46-1.250.08
Net Debt / FCF Ratio
---0.16-0.57-6.110.05
Asset Turnover
1.081.081.451.531.711.63
Inventory Turnover
6.096.0910.9522.4425.8110.87
Quick Ratio
0.730.730.740.840.910.76
Current Ratio
1.181.181.141.161.291.34
Return on Equity (ROE)
5.14%5.14%6.51%6.88%14.19%50.09%
Return on Assets (ROA)
2.43%2.43%3.66%4.39%4.76%9.69%
Return on Invested Capital (ROIC)
8.58%8.09%8.45%10.87%16.53%63.09%
Return on Capital Employed (ROCE)
10.70%10.70%17.00%17.70%16.00%38.00%
Earnings Yield
10.15%10.78%11.17%9.56%14.58%4.71%
FCF Yield
---71.22%73.19%4.70%9.85%
Dividend Yield
1.06%-1.03%1.67%3.92%-
Payout Ratio
--17.17%42.77%--
Buyback Yield / Dilution
-0.85%-0.85%--0.07%-16.93%-2.69%
Total Shareholder Return
0.22%-0.85%1.03%1.61%-13.01%-2.69%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.